CAR-T, Lifesaving Cancer Treatment, May Sometimes Cause Cancer, FDA Says -  The New York Times

CAR-T, Lifesaving Cancer Treatment, May Sometimes Cause Cancer, FDA Says - The New York Times

4.6
(718)
Write Review
More
$ 15.99
Add to Cart
In stock
Description

MY FIRST 100 DAYS AS LLS PRESIDENT & CEO

Why second-line approval of CAR T-cell therapy is needed for blood cancers

Adderall, Ozempic, albuterol, antibiotics and life-saving cancer meds are in short supply. Here's why - Los Angeles Times

Breakthrough for Pharma Industry & Patients - FDA Approved Gene Transfer Therapy

Allogeneic CAR T products: The next frontier in cancer treatment - STAT

A certain kind of cancer treatment may cause new cancer in some patients, FDA warns

/sites/g/files/xnrzdm211/files/style

The Philadelphia Chromosome: A Genetic Mystery, a Lethal Cancer, and the Improbable Invention of a Lifesaving Treatment: Wapner, Jessica, Weinberg, Robert A.: 9781615191970: : Books

Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy